An intact C-terminal end of albumin is required for its long half-life in humans

Autor: Malin C. Bern, Inger Sandlie, Kasper D. Rand, Cláudia Azevedo, Algirdas Grevys, Jan Terje Andersen, Jeannette Nilsen, Bjørn Dalhus, John J Wilson, Maria Stensland, Derry C. Roopenian, Stephen O. Brennan, Kine Marita Knudsen Sand, Esben Trabjerg

Publikováno v: Communications Biology, Vol 3, Iss 1, Pp 1-11 (2020)
Nilsen, J, Trabjerg, E, Grevys, A, Azevedo, C, Brennan, S O, Stensland, M, Wilson, J, Sand, K M K, Bern, M, Dalhus, B, Roopenian, D C, Sandlie, I, Rand, K D & Andersen, J T 2020, ' An intact C-terminal end of albumin is required for its long half-life in humans ', Communications Biology, vol. 3, no. 1, 181 . https://doi.org/10.1038/s42003-020-0903-7
Communications Biology, 3 (1)
Communications Biology

Albumin has an average plasma half-life of three weeks and is thus an attractive carrier to improve the pharmacokinetics of fused therapeutics. The half-life is regulated by FcRn, a cellular receptor that protects against intracellular degradation. T

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ee2ca81be9d054502e8fe07555c5462
http://link.springer.com/article/10.1038/s42003-020-0903-7

Serial serum feline pancreatic lipase immunoreactivity concentrations and prognostic variables in 33 cats with pancreatitis

Autor: Stockhaus, C., Teske, E., Schellenberger, K., Huisinga, E., Konietschke, U., Mangelsdorf, S., Steiner, J.M., Advances in Veterinary Medicine, Geneeskunde van gezelschapsdieren

Publikováno v: Journal of the American Veterinary Medical Association, 243, 1713. American Veterinary Medical Association

Objective—To identify factors significantly associated with prognosis in cats hospitalized because of pancreatitis. Design—Prospective case series. Animals—33 cats hospitalized for treatment of pancreatitis (diagnosis determined on the basis of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f7f0bc67238365bbf57b2c973565fe6
https://dspace.library.uu.nl/handle/1874/314213

Islet Cell Cytoplasmic Antibodies (ICA) in Diabetes and Disorders of Glucose Tolerance

Autor: S. Garne, M. Christy, M. Schroll, Else Marie Damsgaard, E. Heinze, Thomas Mandrup-Poulsen, Åke Lernmark, G. Bille, Jørn Nerup, Simon B. Larsen, B. Marner

Publikováno v: Marner, B, Bille, G, Christy, M, Damsgaard, E M, Garne, S, Heinze, E, Larsen, S, Lernmark, A, Mandrup-Poulsen, T, Nerup, J & Schroll, M 1991, ' Islet cell cytoplasmic antibodies (ICA) in diabetes and disorders of glucose tolerance ', Diabetic medicine : a journal of the British Diabetic Association, vol. 8, no. 9, pp. 812-6 .
Aarhus University

Islet cell cytoplasmic antibodies were determined in 85 individuals 60 to 74 years old with fasting hyperglycaemia, in 65 patients with cystic fibrosis, in 113 patients with pancreatitis, in 21 patients with Turner's phenotype, and in 135 first-degre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3131af9a06028a15e98a8a76c9f08bdc
https://doi.org/10.1111/j.1464-5491.1991.tb02118.x

Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: A randomised controlled trial

Autor: C-L Liu, S-T Fan, C-M Lam, A Tang, W-K Yuen, C Yeung, CM Lo, R T-P Poon

Background: Previous studies suggested that somatostatin given before endoscopic retrograde cholangiopancreatography (ERCP) may reduce the incidence of post-ERCP pancreatitis. However, the routine use of somatostatin in all patients undergoing ERCP i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cd9c7daa999af20ae89b97ed7a3eb70
http://hdl.handle.net/10722/43515

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.